Corrigendum to Polybromo 1/vimentin axis dictates tumor grade, epithelial-mesenchymal transition, and metastasis in pancreatic cancer
Journal of Clinical Investigation · 01.04.2026 · 136 (7)
DOI: 10.1172/jci206371 ↗Kurz gefasst
Korrektur in der Zeitschrift Journal of Clinical Investigation, online erschienen am 01.04.2026. Verfasst von Munenori Kawai und 24 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kawai, M., Fukuda, A., Ikeda, M., Iimori, K., Mizukoshi, K., Iwane, K., Yamakawa, G., Omatsu, M., Namikawa, M., Sono, M., Masuda, T., Fukunaga, Y., Nagao, M., Araki, O., Yoshikawa, T., Ogawa, S., Hiramatsu, Y., Tsuda, M., Maruno, T., …, & Seno, H. (2026). Corrigendum to Polybromo 1/vimentin axis dictates tumor grade, epithelial-mesenchymal transition, and metastasis in pancreatic cancer. Journal of Clinical Investigation, 136(7). https://doi.org/10.1172/jci206371
Vancouver
Kawai M, Fukuda A, Ikeda M, Iimori K, Mizukoshi K, Iwane K, et al. Corrigendum to Polybromo 1/vimentin axis dictates tumor grade, epithelial-mesenchymal transition, and metastasis in pancreatic cancer. Journal of Clinical Investigation. 2026;136(7). doi:10.1172/jci206371
BibTeX
@article{Kawai2026,
author = {Kawai, Munenori and Fukuda, Akihisa and Ikeda, Munehiro and Iimori, Kei and Mizukoshi, Kenta and Iwane, Kosuke and Yamakawa, Go and Omatsu, Mayuki and Namikawa, Mio and Sono, Makoto and Masuda, Tomonori and Fukunaga, Yuichi and Nagao, Munemasa and Araki, Osamu and Yoshikawa, Takaaki and Ogawa, Satoshi and Hiramatsu, Yukiko and Tsuda, Motoyuki and Maruno, Takahisa and Nakanishi, Yuki and Saur, Dieter and Tsuruyama, Tatsuaki and Masui, Toshihiko and Hatano, Etsuro and Seno, Hiroshi},
title = {Corrigendum to Polybromo 1/vimentin axis dictates tumor grade, epithelial-mesenchymal transition, and metastasis in pancreatic cancer},
journal = {Journal of Clinical Investigation},
year = {2026},
volume = {136},
number = {7},
doi = {10.1172/jci206371}
}
EUVIMED